Leveraging strain competition to address antimicrobial resistance with microbiota therapies
The enteric microbiota is an established reservoir for multidrug-resistant organisms that present urgent clinical and public health threats. Observational data and small interventional studies suggest that microbiome interventions, such as fecal microbiota products and characterized live biotherapeu...
Saved in:
| Main Authors: | Danielle Barrios Steed, Dylan Koundakjian, Anthony D. Harris, Adriana E Rosato, Konstantinos T Konstantinidis, Michael H Woodworth |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Gut Microbes |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19490976.2025.2488046 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Straining to define a healthy microbiome
by: Anna M. Seekatz
Published: (2025-07-01) -
Quorum quenching enzymes disrupt bacterial communication in a sex‐ and dose‐dependent manner
by: Aneesh Syal, et al.
Published: (2025-03-01) -
Therapeutic effect of fecal microbiota transplantation on hyperuricemia mice by improving gut microbiota
by: Songjian Yuan, et al.
Published: (2025-08-01) -
Effect of Management System on Fecal Microbiota in Arabian Horses: Preliminary Results
by: Maria Claudia Curadi, et al.
Published: (2025-03-01) -
Fecal microbiota transplantation for hypertension: an exploratory, multicenter, randomized, blinded, placebo-controlled trial
by: Luyun Fan, et al.
Published: (2025-05-01)